1) prothrombinase complex
凝血酶原活酶复合物
1.
Prothrombin was activated by prothrombinase complex simulating the natural condition.
方法以牛血为原料,采用柠檬酸钡吸附、硫酸铵分级沉淀、DEAE-纤维素色谱等方法制备凝血酶原,并模拟生理条件用凝血酶原活酶复合物,包括牛凝血因子Ⅴ、Ⅹa、磷脂和Ca2+对凝血酶原进行激活。
2) prothrombin complex concentrate
凝血酶原复合物
1.
Preparation procedure of human prothrombin complex concentrate by a two-step gel adsorption chromatography process;
采用两步凝胶吸附法制备人凝血酶原复合物的工艺研究
2.
Purpose: The purpose of this study is to prepare prothrombin complex concentrate(PCC) conjugated anionic lipid microbubbles and to assess the physiochemical properties of the microbubbles.
目的:制备结合凝血酶原复合物(PCC)的阴离子脂膜微泡,评价微泡的理化性质。
3.
A method is described for the purification of human prothrombin complex concentrate (PCC) from Nitschmann fraction Ⅲ by membrane radial column ion exchange chromatography,which allows large sample volumes to be processed at low operation pressure.
利用径向离子交换色谱法分离纯化了Nitschmann组分Ⅲ中的凝血酶原复合物 ( prothrombincomplexconcentrate ,PCC) ,流动相为pH 7。
3) Prothrombin complex concentrate(PCC)
凝血酶原复合物(PCC)
4) thrombin/antithrombin complexes
凝血酶抗凝血酶复合物
1.
Objective To measure various coagulation markers such as prothrombin fragment F1+2(F1+2),thrombin/antithrombin complexes(TAT) and D-dimer,and evaluate the outcome of early diagnosis and management of pre-disseminated intravascular(coa)-gulations(pre-DIC) in high-risk neonates.
目的探讨监测危重新生儿血浆凝血酶原片段F1+2、凝血酶抗凝血酶复合物(TAT)及D-二聚体等凝血及纤溶因子水平对弥散性血管内凝血前期(pre-DIC)的诊断及治疗意义。
5) thrombin-antithrombin complex
凝血酶-抗凝血酶复合物
1.
Objective:To detect D-Dimer(DD),thrombin-antithrombin complex(TAT),plasmin-antiplasmin complex(PAP) in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) in order to find their clinical significance in the early diagnosis,treatment and prognosis of COPD.
目的:检测慢性阻塞性肺疾病(COPD)患者在急性加重期血浆D-二聚体(D-D)、凝血酶-抗凝血酶复合物(TAT)、纤溶酶-抗纤溶酶复合物(PAP)含量。
6) Thrombin-antithrombin complexes
凝血酶-抗凝血酶复合物*
补充资料：原活
1.免死;免除死罪。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条